Media members across the political spectrum agreed to recommend the decision by the FDA and CDC to suspend the deployment of the Johnson & Johnson COVID-19 vaccine after six cases of severe blood clots in recipients.
“6 cases. Not 6,000 cases. Not 600 cases. Not 60 cases. 6 cases out of more than 4 million shots fired. Our public health experts still fail us,” Conservative Marc Thiessen wrote.
DO PEOPLE NEED TO BE CENTERED AGAINST CORONAVIRUS?
FiveThirtyEight founder Nate Silver called the decision “a disaster” that is going to kill people and cause more hesitation against vaccines. Vice-Chair of the Media Research Center, Dan Gainor quotes Silver’s tweetand adds, “I can not agree with this.”
Keith Olbermann, who even seems to be too liberal for ESPN, had a similar view.
“You’d think the FDA would know from all the people about the impossibility of putting the toothpaste back in the tube. It’s a moronic step based on six cases. Moronic,” Olbermann wrote, perhaps the first time he was on was the same page. as conservatives like Theissen and Gainor.
Left Former Lincoln Project Advisor Kurt Bardella agreed“It will help the madness of anti-vaxxers and strengthen the vaccination of the vaccine. Now even more people will have the license to get vaccinated and thus enable the continuous spread of this virus and its variants.”
FDA RECOMMENDS OF PAUSE OF JOHNSON & JOHNSON COVID-19 VACCINE AFTER BLOOD CONSEQUENCES
Many other media members from left, right and center took to Twitter to make the decision:
Some agree with the decision and think that the call for a halt represents something more serious than the reported blood clots. White House adviser Anthony Fauci said on Tuesday he did not believe it was pulling the trigger too fast.
The decision succeeds conservatives and far left to briefly agree on something, but the FDA maintains that it was not taken lightly.
“At the moment, these adverse events appear to be extremely rare,” said the agency on Twitter. “The treatment of this particular type of blood clot differs from the treatment that can usually be administered. The CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further investigate these cases and assess their potential importance. FDA will review the analysis as it also examines these matters. ‘
However, until the investigation is completed, the FDA recommends this break.
CLICK HERE TO GET THE FOX NEWS APP
In a statement provided to Fox News, Johnson and Johnson said that the “safety and well-being of people who use our products” is the top priority of the company and that they are aware of an “extremely rare disease that people with blood clots in combination with low blood platelets in a small number of individuals who received our COVID-19 vaccine. ‘
Fox News’ Alexandria Hein and David Rutz contributed to this report.